Management of Hypopituitarism: a Perspective from the Brazilian Society of Endocrinology and Metabolism

Hypopituitarism is a disorder characterized by insufficient secretion of one or more pituitary hormones. New etiologies of hypopituitarism have been recently described, including head trauma, cerebral hemorrhage, and drug-induced hypophysitis. The investigation of patients with these new disorders, in addition to advances in diagnosis and treatment of hypopituitarism, has increased the prevalence of this condition. Pituitary hormone deficiencies can induce significant clinical changes with consequent increased morbidity and mortality rates, while hormone replacement based on current guidelines protects these patients. In this review, we will first discuss the different etiologies of hypopituitarism and then address one by one the clinical aspects, diagnostic evaluation, and therapeutic options for deficiencies of TSH, ACTH, gonadotropin, and GH. Finally, we will detail the hormonal interactions that occur during replacement of pituitary hormones.

Citing Articles

Hypopituitarism presenting with cardiovascular manifestations: a case report.

Zhen X, Li Y, Ren C, Li M BMC Cardiovasc Disord. 2025; 25(1):117.

PMID: 39972417 PMC: 11837320. DOI: 10.1186/s12872-025-04535-9.

Altered amino acid levels in young hypopituitarism: impact of NAFLD and insulin resistance.

Zhang Y, Qiu J, Sun S, Fang X Amino Acids. 2024; 56(1):65.

PMID: 39580591 PMC: 11585508. DOI: 10.1007/s00726-024-03429-y.

Progress, challenges and perspectives in the management of hypopituitarism.

Boguszewski C, Neggers S Rev Endocr Metab Disord. 2024; 25(3):453-455.

PMID: 38801648 DOI: 10.1007/s11154-024-09889-7.

Childhood-Onset GH Deficiency versus Adult-Onset GH Deficiency: Relevant Differences Regarding Insulin Sensitivity.

Garmes H, Castillo A, Monte Alegre S, de Souza A, Atala Y, Zantut-Wittmann D Metabolites. 2022; 12(12).

PMID: 36557289 PMC: 9782045. DOI: 10.3390/metabo12121251.

Central adrenal insufficiency: who, when, and how? From the evidence to the controversies - an exploratory review.

Bitencourt M, Batista R, Biscotto I, Carvalho L Arch Endocrinol Metab. 2022; 66(4):541-550.

PMID: 35758836 PMC: 10697652. DOI: 10.20945/2359-3997000000493.

References

Byun D, Wolchok J, Rosenberg L, Girotra M . Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol. 2017; 13(4):195-207. PMC: 5629093. DOI: 10.1038/nrendo.2016.205. View

Jasim S, Alahdab F, Ahmed A, Tamhane S, Prokop L, Nippoldt T . Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine. 2016; 56(1):33-42. DOI: 10.1007/s12020-016-1159-3. View

Schneider H, Aimaretti G, Kreitschmann-Andermahr I, Stalla G, Ghigo E . Hypopituitarism. Lancet. 2007; 369(9571):1461-1470. DOI: 10.1016/S0140-6736(07)60673-4. View

Hacioglu A, Kelestimur F, Tanriverdi F . Long-term neuroendocrine consequences of traumatic brain injury and strategies for management. Expert Rev Endocrinol Metab. 2020; 15(2):123-139. DOI: 10.1080/17446651.2020.1733411. View

Boguszewski C . Update on GH therapy in adults. F1000Res. 2017; 6:2017. PMC: 5691372. DOI: 10.12688/f1000research.12057.1. View

Xatzipsalti M, Voutetakis A, Stamoyannou L, Chrousos G, Kanaka-Gantenbein C . Congenital Hypopituitarism: Various Genes, Various Phenotypes. Horm Metab Res. 2019; 51(2):81-90. DOI: 10.1055/a-0822-3637. View

Clemmons D, Molitch M, Hoffman A, Klibanski A, Strasburger C, Kleinberg D . Growth hormone should be used only for approved indications. J Clin Endocrinol Metab. 2014; 99(2):409-11. PMC: 5393472. DOI: 10.1210/jc.2013-4187. View

Mazziotti G, Mormando M, Cristiano A, Bianchi A, Porcelli T, Giampietro A . Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. Eur J Endocrinol. 2014; 170(6):893-9. DOI: 10.1530/EJE-14-0097. View

Higham C, Johannsson G, Shalet S . Hypopituitarism. Lancet. 2016; 388(10058):2403-2415. DOI: 10.1016/S0140-6736(16)30053-8. View

10.

Zhu D, Chung H, Dobson A, Pandeya N, Brunner E, Kuh D . Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies. Hum Reprod. 2020; 35(8):1933-1943. PMC: 8453420. DOI: 10.1093/humrep/deaa124. View

11.

Rosen T, Bengtsson B . Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990; 336(8710):285-8. DOI: 10.1016/0140-6736(90)91812-o. View

12.

van der Klaauw A, Biermasz N, Feskens E, Bos M, Smit J, Roelfsema F . The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. Eur J Endocrinol. 2007; 156(4):455-62. DOI: 10.1530/EJE-06-0699. View

13.

Molitch M, Clemmons D, Malozowski S, Merriam G, Vance M . Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(6):1587-609. DOI: 10.1210/jc.2011-0179. View

14.

Monaghan P, Keevil B, Trainer P . The use of mass spectrometry to improve the diagnosis and the management of the HPA axis. Rev Endocr Metab Disord. 2013; 14(2):143-57. DOI: 10.1007/s11154-013-9240-1. View

15.

Ribeiro R, Abucham J . Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment. Eur J Endocrinol. 2009; 161(1):163-9. DOI: 10.1530/EJE-09-0084. View

16.

Pappachan J, Raskauskiene D, Raman Kutty V, Clayton R . Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J Clin Endocrinol Metab. 2015; 100(4):1405-11. DOI: 10.1210/jc.2014-3787. View

17.

Friedman C, Proverbs-Singh T, Postow M . Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review. JAMA Oncol. 2016; 2(10):1346-1353. DOI: 10.1001/jamaoncol.2016.1051. View

18.

Doin F, Rosa-Borges M, Martins M, Moises V, Abucham J . Diagnosis of subclinical central hypothyroidism in patients with hypothalamic-pituitary disease by Doppler echocardiography. Eur J Endocrinol. 2012; 166(4):631-40. DOI: 10.1530/EJE-11-0907. View

19.

Ribeiro-Oliveira Jr A, Simao Mol S, Twiss J, Alencar G, Miranda P, Naves L . The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Four-stage translation and validation. Arq Bras Endocrinol Metabol. 2011; 54(9):833-41. DOI: 10.1590/s0004-27302010000900010. View

20.

Allen D, Backeljauw P, Bidlingmaier M, Biller B, Boguszewski M, Burman P . GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2015; 174(2):P1-9. PMC: 4674592. DOI: 10.1530/EJE-15-0873. View